Perhaps in the future allergies will be defeated

Of the existing types of allergies, peanut Allergy is one of the strongest. There are cases when the person with this form of Allergy enough to kiss another man, who just yesterday ate peanuts, as he develops the strongest anaphylactic shock, writes The Daily Mail. Therefore, people with this form of Allergy should always carry syringes in the form of pens, "charged" by epinephrine.

But, it seems that doctors have figured out how to overcome this Allergy. In their opinion, it is necessary to use the sublingual therapy, during which the person under the tongue Kapitsa a few drops of the allergen, the dose which increases gradually until the person does not become immune to this stuff, is written on the pages of the journal of Allergy and Clinical Immunology.

In this case, patients are suggested introducing a few droplets of the liquid with the powder of peanuts. In this experiment agreed to participate, 40 volunteers aged from 12 to 37 years. Some of them got really allergen, and someone was applied to the phenomenon of placebo. Patients kept liquid for 2 minutes, then swallowed it. As stated by Dr. Wesley Berks from Medical school at the University of North Carolina, he is very happy and appreciates the results of the experiment.

Initially it was decided to give the volunteers a dose of 2 grams of powder to set the lower threshold of acceptable norms. After 11 months, the second phase of the experiment, during which, those test subjects who were able to consume 5 grams of powder and more passed a group of people with a low sensitivity to peanuts.

This group included 70 percent of the original number of Allergy sufferers who took part in the experiment. In the second stage, the volume of the powder is increased to 5 grams, and 68 weeks later the amount of powder was equal to 996 to milligrams. The placebo group consisted of 15% of such people. Just been issued 10855 doses, of which 63 percent did not cause allergic effect.

Dr. Berkes and Fleischer, in General, satisfied with the results, because the immune response was more powerful than they expected, but at the same time, the therapeutic effect was weaker than expected. In this direction they intend to continue their research.

Subscribe to new posts: